Carotid artery intima-media thickness and brachial artery flow-mediated vasodilatation in patients with rheumatoid arthritis;Carotis Intima-Media-Dicke und flow-vermittelte Vasodilatation bei Patienten mit rheumatoider Arthritis

Vasa - Journal of Vascular Diseases

Volumn 41, Issue 5, 2012, Pages 343-351

  Veselinovic, Mirjana V ^a   Zivkovic, Vladimir I ^b   Toncev, Slavco ^a   Tasic, Nebojsa ^c   Bogdanovic, Vesna ^d   Djuric, Dragan M ^e   Jakovljevic, Vladimir Lj ^b  

^a CLINICAL CENTER KRAGUJEVAC   (Serbia)

^b Department of Physiology   (Serbia)

^c Institute for Cardiovascular Disease Dedinje   (Serbia)

^d Health Center Zvezdara   (Serbia)

^e Faculty of Medicine   (Serbia)

Author keywords

Flow mediated vasodilatation; Intima media thickness; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYCHLOROQUINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; RHEUMATOID FACTOR; STEROID;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BRACHIAL ARTERY; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DRUG MEGADOSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RHEUMATOID ARTHRITIS; RISK FACTOR; VASODILATATION; VISUAL ANALOG SCALE;

ADULT; ARTHRITIS, RHEUMATOID; BRACHIAL ARTERY; CAROTID ARTERY DISEASES; EARLY DIAGNOSIS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPEREMIA; MALE; MIDDLE AGED; REFERENCE VALUES; TUNICA INTIMA; TUNICA MEDIA; VASODILATION;

EID: 84865821705     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526/a000220     Document Type: Article

References (30)

1. Ahmad S, Garg S, Dhar M, Srivastara S, Biswas D, Barthwal SP, Shirazi N, Srivastara R. Predictors of atherosclerosis in rheumatoid arthritis. Vasa 2012; 41: 353-59.
2. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31: 315-24.
3. Barth, JD. An update on carotid ultrasound measurement of intimamedia thickness. Am J Cardiol 2002; 89: 328-98.
4. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23: 168-175.
5. Boyer JF, Gourraud PA, Cantagrel A, Davignon JL, Constantin A. Traditional cardiovascular risk factors in rheumatoid arthritis: a metaanalysis. Joint Bone Spine 2011; 78 (2): 179-183.
6. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: Dimensions and Practical Applica tions. Health Qual Life Outcomes 2003; 1: 20.
7. Correti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R. Guidelines for the ultrasound assessment of endothelial-dependet flow mediated vasodilatation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39 (2): 257-265.
8. Davis JM 3rd, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, Roger VL, Gabriel SE. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2007; 56 (3): 820-830.
9. Djuric D, Popovic Z, Petrovic J, Bojic M. Age-related progressive brachial artery endothelial dysfunction precedes the changed carotid and left ventricular geometry in healthy humans. Angiology 1999; 50 (7): 555-561.
10. Evans MR, Escalante A, Battafarano DF, Freeman GL, O'Leary DH, del Rincón I. Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis. Arthritis Rheum 2011; 63 (5): 1211-1220.
11. Garcia-Bermudez M, González-Juanatey C, Lopez-Mejias R, Rodriguez-Rodriguez L, Pérez-Esteban S, Castañeda S, Urcelay E, Miranda-Filloy JA, Gómez-Vaquero C, Fernández-Gutierrez B, Balsa A, González-Alvaro I, Blanco R, Llorca J, Martín J, Gonzalez-Gay MA. Influence of MHCIITA rs3087456 and rs4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis. Clin Exp Rheumatol 2012 Jan 23. [Epub ahead of print]
12. Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Piñeiro A, Garcia-Porrua C, Miranda-Filloy JA, Ollier WE, Martin J, Llorca J. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum. 2007; 57 (1): 125-132.
13. Gonzalez-Gay MA, Gonzalez-Juanatey C, Pineiro A, Garcia-Porrua C, Testa A, Llorca J. Highgrade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 2005; 32: 1219-1223.
14. Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Martin J, Llorca J. Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis. Semin Arthritis Rheum 2008; 38 (2): 67-70.
15. Gonzalez-Juanatey C, Llorca J, Garcia-Porrua C, Sanchez-Andrade A, Martín J, Gonzalez-Gay MA. Steroid therapy improves endothelial function in patients with biopsyproven giant cell arteritis. J Rheumatol 2006; 33 (1): 74-78.
16. Gonzalez-Juanatey C, Llorca J, Martin J, Gonzalez-Gay MA. Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum 2009; 38 (5): 366-371.
17. Gonzalez-Juanatey C, Llorca J, Testa A, Revuelta J, Garcia-Porrua C, Gonzalez-Gay MA. Increased prevalence of severe subclinical atherosclerotic findings in longterm treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore) 2003; 82 (6): 407-413.
18. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Vidan J, Hajeer AH, Ollier WE, Mattey DL, Gonzalez-Gay MA. HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med 2003; 114 (8): 647-652.
19. Grover S, Sinha RP, Singh U, Tewari S, Aggarwal A, Misra R. Subclinical atherosclerosis in rheumatoid arthritis in India. J Rheumatol. 2006; 33 (2): 244-247.
20. Libby P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 2008; 121: S21-S31.
21. O'Leary DH, Bots ML. Imaging of atherosclerosis: carotid intimamedia thickness. Eur Heart J 2010; 31 (14): 1682-1689.
22. Prevoo ML, t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eightjoint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-48.
23. Rodríguez-Rodríguez L, González-Juanatey C, García-Bermúdez M, Vázquez-Rodríguez TR, Miranda-Filloy JA, Fernández-Gutiérrez B, Llorca J, Martin J, González-Gay MA. CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study. Arthritis Res Ther 2011; 13 (4): R133.
24. Rodríguez-Rodríguez L, González-Juanatey C, Palomino-Morales R, Vázquez-Rodríguez TR, Miranda-Filloy JA, Fernández-Gutiérrez B, Llorca J, Martin J, González-Gay MA. TNFA-308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis 2011; 216 (1): 125-130.
25. Sitia S, Tomasoni I, Atzeni F, Ambrosio G, Cordiano C, Catapano A, Tramontana S, Perticone F, Naccarato P, Camici P, Picano E, Cortigiani L, Bevilacqua M, Milazzo L, Cusi D, Barlassina C, Sarzi-Puttini P, Turiel M. From endothelial dys function to atherosclerosis. Autoimmun Rev 2010; 9 (12): 830-834.
26. Soltesz P, Kerekes G, Der H, Szucs G, Szanto S, Kiss E, Bodolay E, Zeher M, Timar, Szodoray P, Szegedi G and Szekanecz Z. Comparative assesment of vascular function in autoimmune rheumatic disease: Considerations of prevention and treatment. Autoimmunity Reviews 2011; 10: 416-425.
27. Steiner G, Urowitz MB. Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin Arthritis Rheum. 2009; 38 (5): 372-381.
28. Superko HR, Gadesam RR. Is it LDL particle size or number that correlates with risk for cardiovascular disease? Curr Atheroscler Rep 2008; 10 (5): 77-85.
29. Svensson B, Hafström I. Effects on joint destruction and remission, bone turnover and lack of influence on atherogenesis: a review of the BARFOT low-dose prednisolone studies on patients with early RA. Clin Exp Rheumatol 2011; 29 (5 Suppl 68): S63-S67.
30. Targońska-Stepniak B, Drelich-Zbroja A, Majdan M. The relationship between carotid intima-media thickness and the activity of rheumatoid arthritis. J Clin Rheumatol. 2011; 17 (5): 249-255.